AN2 Therapeutics, Inc. (ANTX) Net income 2021–2025
AN2 Therapeutics, Inc. (ANTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$35.2MFY2025 · since FY2021: -$21.5M → -$35.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.2M | +31.5% |
| FY2024 | -$51.3M | +20.7% |
| FY2023 | -$64.7M | -58.1% |
| FY2022 | -$41.0M | -90.1% |
| FY2021 | -$21.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANTX financial trends
ANTX RevenueANTX Net marginANTX Gross profitANTX Gross marginANTX Operating incomeANTX Operating marginANTX Operating cash flowANTX Free cash flowANTX Capital expendituresANTX Return on equityANTX Stock buybacksANTX Dividends paidANTX Total assetsANTX Total liabilitiesANTX Shareholders’ equityANTX overview →